Neurocrine Biosciences NBIX Business Segments — Selling, general, and administrative

Similar metrics at other companies

ARQTReportable Segment — Selling, general, and administrative

$73.95M+15.8%

NVAXReportable Segment — Selling, general, and administrative

$28.78M-40.2%

MNTSReportable Segment — Selling, general and administrative expenses

$6.34M+38.1%

BAE

BAERReportable Segment — Selling, general and administrative expense

$9.07M+1.3%

CENXReportable Segment — Selling, general and administrative expenses

$25.8M+106%

SIFReportable Segment — Selling, general and administrative expenses

$2.99M+27.0%

Questions, answered.

What is Neurocrine Biosciences's business segments — selling, general, and administrative?

Neurocrine Biosciences (NBIX) reported business segments — selling, general, and administrative of $318.5M in Q1 2026.

How has Neurocrine Biosciences's business segments — selling, general, and administrative changed year-over-year?

Neurocrine Biosciences's business segments — selling, general, and administrative increased by 15.2% year-over-year, from $276.5M to $318.5M.

What is the long-term trend for Neurocrine Biosciences's business segments — selling, general, and administrative?

Over 3 years (2022 to 2025), Neurocrine Biosciences's business segments — selling, general, and administrative has grown at a 15.4% compound annual growth rate (CAGR), from $752.7M to $1.16B.

What does business segments — selling, general, and administrative mean?

Encompasses the overhead costs of running the business, including sales force expenses, marketing, legal, and corporate administration. This metric measures the operational leverage and cost discipline of the organization.